Bulletin
Investor Alert

New York Markets Close in:

Market Snapshot Winners and Losers

Alexion Pharmaceuticals Inc.

NAS: ALXN

GO

Set Alerts

Market Index

Overview Profile Charts Financials Historical Quotes Analyst Estimates Options SEC Filings Insiders
/marketstate/country/us
Alexion Pharmaceuticals Inc.

Market open

ALXN
/zigman2/quotes/206262068/composite

$

96.15

Change

+1.43 +1.51%

Volume

Volume 25,157

Apr 8, 2020, 9:34 a.m.

Real time quotes

/zigman2/quotes/206262068/composite

Previous close

$ 94.72

$ 96.15

Change

+1.43 +1.51%

Day low

Day high

$95.49

$96.38

Open
Open: 95.87

52 week low

52 week high

$72.67

$141.86

Open

Market cap

$21.04B

Average volume

2.78M

P/E ratio

8.83

Rev. per Employee

$1.56M

EPS

10.72

Dividend

N/A

Div yield

N/A

Ex dividend date

N/A

Compare:
Indexes
  • Dow(INDU) INDU
  • Nasdaq (COMP) COMP
  • S&P 500 (SPX) SPX
  • Global Dow (GDOW) GDOW
1d
5d
3m
6m
1y
3y
5y
/news/latest/company/us/alxn

MarketWatch News on ALXN

  2. Biopharma Could Outperform Volatile Market, Analyst Says

    1:28 p.m. March 5, 2020

    - Barron's Online

  4. Alexion Pharmaceuticals stock price target raised to $165 from $133 at Instinet

    10:05 a.m. Feb. 3, 2020

    - Tomi Kilgore

  5. Alexion Pharmaceuticals stock price target cut to $161 from $170 at Raymond James

    9:21 a.m. Jan. 8, 2020

    - Tomi Kilgore

  6. Apellis Stock Soars After Head-to-Head Drug Trial Vs Alexion

    11:30 a.m. Jan. 7, 2020

    - Barron's Online

  8. Top stock picks for 2020: The best of the biggest

    5:18 p.m. Dec. 28, 2019

    - Philip van Doorn

  9. The Biotech Sector Is Roaring Into 2020. Here’s Why.

    2:20 p.m. Dec. 27, 2019

    - Barron's Online

  10. Here’s how Wall Street’s favorite stock picks turned out in 2019

    10:48 a.m. Dec. 21, 2019

    - Philip van Doorn

  11. Alexion Pharmaceuticals downgraded to equal weight at Morgan Stanley

    10:54 a.m. Dec. 17, 2019

    - Tomi Kilgore

  13. Alexion stocks rises on decision not to consider a sale

    10:37 a.m. Dec. 6, 2019

    - Jaimy Lee

  14. The Dow Goes Negative Despite a Glimmer of Hope on Trade

    1:57 p.m. Dec. 5, 2019

    - Barron's Online

  16. Buy Big Biotech — But Not Gilead, Analyst Says

    12:38 p.m. Nov. 12, 2019

    - Barron's Online

  17. How to invest in biotech stocks like a Nobel Prize winner

    11:47 a.m. Oct. 24, 2019

    - Michael Brush

  18. Alexion Pharmaceuticals upgraded to strong buy from buy at CFRA

    2:02 p.m. Oct. 23, 2019

    - Tomi Kilgore

  21. Loading more headlines...

Analyst Ratings

/news/nonmarketwatch/company/us/alxn

Other News on ALXN

  1. Alnylam, Dicerna Join Forces to Take on Arrowhead

    4:26 p.m. April 6, 2020

    - GuruFocus.com

  3. 6 Healthcare Companies Boosting Book Value

    11:04 a.m. April 2, 2020

    - GuruFocus.com

  7. 3 Covid-19 Proof Biotech Stocks

    4:27 a.m. March 30, 2020

    - Seeking Alpha

  10. Major Biotechs Get Mixed Message on Short Interest

    8:55 a.m. March 25, 2020

    - 247WallSt.com

  12. 26 Benjamin Graham-inspired stock picks

    9:19 a.m. March 23, 2020

    - Seeking Alpha

  13. Largest Insider Trades of the Week

    3:04 p.m. March 22, 2020

    - GuruFocus.com

  14. Daily Insider Ratings Round Up 3/18/20

    9:38 p.m. March 19, 2020

    - Seeking Alpha

  15. 10 Stocks With Little or No Debt to Own for the Next 50 Years 

    8:37 a.m. March 19, 2020

    - InvestorPlace.com

  17. Why Did Oppenheimer Downgrade Alexion Pharmaceuticals’ Stock?

    6:58 a.m. March 17, 2020

    - SmarterAnalyst

  18. 10-K: FORTRESS BIOTECH, INC.

    4:56 p.m. March 16, 2020

    - Edgar Online - (EDG = 10Q, 10K)

  19. The Coronavirus Market Survival Guide

    6:16 a.m. March 16, 2020

    - Seeking Alpha

  20. Big Biotechs Have Short Sellers Confused

    8:41 a.m. March 11, 2020

    - 247WallSt.com

  21. Loading more headlines...
/news/pressrelease/company/us/alxn

Press Releases on ALXN

  2. OraSure Technologies Appoints David J. Shulkin, M.D. to Board of Directors

    6:00 a.m. Today

    - GlobeNewswire

  8. Global Orphan Drug Clinical Trials, Patent & Guidelines Insight 2026

    2:05 p.m. April 1, 2020

    - PR Newswire - PRF

  12. Eculizumab Drug Market Technological Trends in 2020-2029 | Alexion,

    12:10 p.m. March 25, 2020

    - marketresearch.biz

  21. Loading more headlines...

Rates »

Mortgage Equity Savings Auto
Link to MarketWatch's Slice.